measur
monitor
biochem
paramet
blood
glucos
blood
gase
electrolyt
cardiac
marker
particularli
benefit
recent
advanc
poct
form
analysi
posit
impact
field
infecti
diseas
well
trend
driven
one
hand
method
improv
make
possibl
miniatur
simplifi
test
system
chapter
constant
demand
mani
physician
immedi
test
result
meanwhil
rang
microbiolog
paramet
avail
poc
extend
consider
tabl
poct
result
howev
alway
regard
interpret
context
clinic
symptom
current
epidemiolog
situat
proper
handl
poct
system
strict
consider
preanalyt
limit
decis
obtain
reliabl
test
result
mani
microbiolog
poct
system
tend
design
rapid
test
gener
test
carri
simpl
step
medic
assist
physician
without
laboratori
equip
laboratori
experi
evalu
test
result
deliv
patient
bedsid
within
one
hour
certain
circumst
patient
even
carri
test
exampl
rapid
hiv
malaria
test
rapid
microbiolog
test
usual
verifi
microbi
antigen
less
often
diagnost
base
detect
antibodi
eg
rapid
hiv
test
rapid
detect
heterophil
antibodi
diagnos
infecti
mononucleosi
tabl
respiratori
tract
secret
often
use
detect
microbi
antigen
patient
respiratori
tract
infect
influenza
viru
respiratori
syncyti
viru
streptococcu
pyogen
similarli
stool
specimen
patient
gastrointestin
tract
infect
helicobact
pylori
shiga
toxinproduc
e
coli
adenoviru
rotaviru
examin
howev
correspond
urin
test
also
avail
detect
antigen
legionella
pneumococc
infect
blood
sampl
usual
use
detect
antibodi
hiv
infecti
mononucleosi
particular
case
saliva
sampl
also
use
rapid
hiv
selftest
perspect
infecti
diseas
specialist
poc
test
alway
indic
case
lifethreaten
infect
requir
immedi
target
treatment
time
advantag
associ
poct
convent
diagnost
truli
come
bear
total
analysi
time
need
rapid
test
usual
minut
even
optim
condit
analysi
central
laboratori
compet
unless
test
carri
directli
hospit
lab
often
take
least
hour
transport
specimen
laboratori
time
need
actual
analysi
includ
necessari
prepar
pipet
incub
etc
addit
time
taken
report
result
back
request
physician
therefor
even
urgent
request
total
analysi
time
day
mani
welldocu
case
infecti
diseas
medicin
particularli
critic
care
medicin
time
save
confer
benefici
effect
therapeut
outcom
kumar
et
al
shown
surviv
rate
sepsi
patient
intens
care
correl
directli
earli
clinic
effect
initi
antibiot
treatment
treatment
delay
hour
lower
surviv
rate
much
decis
treatment
lifethreaten
highli
acut
infect
sepsi
also
gener
decis
need
made
within
short
time
frame
consider
facilit
poct
immedi
avail
rapid
hiv
test
result
exampl
help
decisionmak
prophylact
antiretrovir
treatment
childbirth
peopl
occup
exposur
hiv
intrapartum
detect
group
b
streptococci
women
labor
detect
plasmodia
spp
includ
selftest
patient
suspect
malaria
infect
similar
situat
poct
prove
merit
presenc
pathogen
detect
immedi
use
antigen
test
whereupon
earli
target
antimicrobi
therapi
lessen
even
prevent
infect
poct
also
use
guid
treatment
viral
infect
effect
zanamivir
oseltamivir
influenza
treatment
depend
given
later
hour
first
symptom
develop
approach
similar
respiratori
syncyti
viru
rsv
studi
shown
treatment
ribavirin
rsv
bronchopneumonia
success
initi
earli
enough
besid
play
role
decisionmak
aid
individu
patient
poct
also
design
prevent
spread
infect
transmiss
prophylaxi
target
situat
aris
hospit
risk
undetect
pathogen
spread
patient
patient
also
constel
transmiss
risk
associ
outpati
exampl
well
known
high
percentag
patient
come
hiv
sexual
health
clinic
skip
followup
appoint
fear
unfavor
diagnosi
although
avoid
behavior
understand
problem
insofar
test
result
usual
confirm
infect
hiv
gonorrhea
chlamydia
infect
farreach
consequ
patient
well
sexual
partner
data
usa
spotlight
extent
problem
one
studi
hiv
clinic
quarter
peopl
seek
advic
undergo
convent
hiv
test
attend
schedul
followup
appoint
pick
test
result
differ
rapid
hiv
test
perform
peopl
rapid
test
left
clinic
receiv
test
result
gener
rapid
microbiolog
test
like
test
method
subject
varieti
preanalyt
analyt
confound
influenc
factor
neg
impact
diagnost
conclus
find
problem
clearli
illustr
use
rapid
influenza
diagnost
test
exampl
follow
signific
impact
choic
specimen
taken
nasal
wash
better
throat
swab
specimentak
instrument
swab
gel
gener
less
use
without
patient
activ
immedi
test
exampl
amount
detect
viru
reduc
patient
eaten
drunk
gargl
influenc
factor
includ
time
sampl
collect
prefer
first
day
diseas
onset
viru
shed
declin
rapidli
age
person
children
shed
influenza
virus
higher
rate
adult
rapid
test
also
affect
similar
confound
influenc
factor
fact
mani
rapid
microbiolog
test
suppli
appar
easytous
format
eg
form
strip
cassett
cartridg
prepackag
diagnost
reagent
singleus
dispos
devic
deceiv
handl
test
trivial
rather
problemat
especi
come
sampl
collect
inde
evalu
studi
rapid
detect
test
streptococci
clearli
shown
qualiti
reliabl
test
result
essenti
depend
train
experi
person
take
throat
swab
perform
rapid
test
moreov
rapid
streptococc
test
rel
subject
read
endpoint
often
make
interpret
prone
error
particular
increas
infect
risk
examin
one
disadvantag
specif
afflict
infecti
diseas
medicin
complet
avoid
test
examin
expos
patient
specimen
respiratori
secret
stool
urin
blood
potenti
contain
pathogen
poct
method
continu
develop
improv
past
year
major
test
nowaday
use
immunochromatographi
chapter
moder
high
sensit
rel
high
specif
except
case
like
rapid
hiv
test
today
poct
method
achiev
result
inde
reliabl
convent
diagnost
poct
system
potenti
limit
sensit
suspect
pathogen
eg
influenza
virus
rsv
rotavirus
norovirus
adenovirus
may
compromis
pattern
season
variat
preval
organ
consider
impact
clinic
reliabl
test
exemplifi
immunochromatograph
rapid
influenza
diagnost
test
fig
low
preval
exampl
given
expect
start
season
flu
outbreak
despit
high
sensit
exampl
high
specif
neg
predict
valu
test
expect
significantli
higher
posit
predict
valu
rapid
test
show
falseposit
often
trueposit
result
circumst
preval
rise
certainli
happen
sever
flu
outbreak
posit
predict
valu
increas
cours
biostatist
relationship
shown
hold
true
infecti
diseas
follow
season
pattern
well
word
use
test
limit
sensit
yield
fals
result
start
outbreak
preval
still
low
turn
could
certainli
lead
underappreci
extent
diseas
must
taken
account
use
poct
convent
rapid
test
unabl
detect
prevail
antibiot
resist
therefor
import
inform
therapeut
option
may
lack
epidemiolog
pattern
regard
develop
resist
bacteri
strain
longer
detect
els
becom
appar
later
immunolog
test
certain
limit
detect
difficult
owe
limit
amount
microbi
antigen
releas
particular
regard
colon
mucou
membran
associ
low
pathogen
count
eg
group
b
streptococcu
vagina
intracellular
pathogen
eg
chlamydia
cervic
smear
new
test
concept
develop
order
detect
pathogen
given
degre
analyt
sensit
requir
pcr
method
nucleic
acid
amplif
techniqu
nat
greater
sensit
ad
diagnost
arsen
develop
faster
easier
use
import
innov
context
develop
fulli
autom
pcr
kit
readytous
reagentco
singleus
cartridg
pcr
step
sampl
exposur
amplif
detect
run
sequenc
without
manual
input
market
leader
genexpert
system
suppli
cepheid
chapter
fulli
autom
pcr
devic
easi
use
possibl
train
staff
carri
test
near
patient
outsid
laboratori
set
american
food
drug
administr
fda
approv
genexpert
rapid
test
accord
clia
criteria
present
techniqu
list
moder
complex
categori
reserv
accredit
laboratori
cliawaiv
classif
mean
without
subject
laboratori
use
still
pend
addit
primari
function
pathogen
detect
pcr
also
use
simultan
analysi
resist
determin
virul
factor
link
assay
incorpor
multiplex
technolog
allow
complex
question
process
within
one
pcr
run
eg
detect
follow
aureu
plu
detect
methicillin
resist
meca
two
determin
vana
vanb
vancomycin
resist
enterococci
clostridium
difficil
toxin
b
also
encompass
binari
toxin
tcdc
delet
detect
highli
virul
variant
mycobacterium
tuberculosi
also
encompass
rifampicin
resist
rpo
detect
multidrug
resist
tuberculosi
strain
simultan
detect
influenza
influenza
b
recent
avail
isystem
aler
reli
isotherm
amplif
detect
influenza
ab
virus
group
streptococci
chapter
boast
significantli
better
sensit
specif
compar
antigen
detect
method
correspondingli
reliabl
result
besid
isystem
aler
also
offer
qanalyz
fulli
autom
nat
platform
rapid
molecular
biolog
test
method
isotherm
basi
increasingli
use
diagnost
tropic
viral
infect
well
veterinari
virolog
suppli
portabl
case
lab
provid
advantag
area
littl
infrastructur
deliv
reliabl
result
overview
avail
assay
nearpati
molecular
biolog
test
system
shown
tab
progress
pcr
nat
technolog
made
nearpati
test
access
seri
pathogen
infecti
diseas
current
exist
lack
clariti
molecular
biolog
test
medic
econom
feasibl
patient
need
scientif
evalu
disadvantag
cite
constant
critic
rais
regard
poct
method
pertain
extra
cost
incur
new
system
even
assum
nearpati
diagnost
save
laboratori
test
associ
cost
poct
process
gener
molecular
assay
particular
significantli
expens
convent
laboratori
test
moreov
poct
creat
extra
work
staff
previous
involv
diagnost
task
possibl
need
consid
job
plan
question
inevit
aris
far
nearpati
microbiolog
analysi
actual
add
valu
justifi
ad
financi
expenditur
comprehens
review
topic
rare
avail
give
full
pictur
either
main
difficulti
issu
relat
weigh
costeffect
medic
benefit
nearpati
test
multifactori
complex
aspect
beyond
close
interlink
therefor
possibl
find
global
solut
fact
welljustifi
estim
depend
much
circumst
individu
case
addit
intern
studi
data
simpli
appli
situat
germani
hospit
charg
health
insur
compani
use
german
diagnosisrel
group
drg
system
howev
expect
poct
system
soon
play
increas
role
gener
medic
care
futur
densiti
physician
coverag
project
decreas
lead
signific
deterior
patient
care
particularli
lowland
rural
area
counteract
new
way
must
found
maintain
high
qualiti
care
nonmetropolitan
area
poctbas
laboratori
diagnost
gain
relev
closer
look
molecular
mrsa
screen
illustr
conflict
costeffect
one
hand
medic
benefit
modern
pcr
test
nasal
mrsa
colon
detect
faster
reliabl
mani
routin
cultur
method
indisput
sooner
appropri
hygien
measur
put
place
posit
mrsa
statu
identif
lower
risk
infect
spread
patient
term
cost
mrsa
cultur
approx
approx
posit
result
versu
pcr
singletest
cartridg
approx
pcr
least
time
expens
cultur
method
howev
addit
cost
pcr
test
may
justifi
consid
everi
mrsa
transmiss
prevent
earli
detect
save
hospit
sever
thousand
euro
ad
cost
therefor
costbenefit
ratio
shift
favor
pcr
even
case
balanc
success
code
drg
flat
rate
payment
system
ad
cost
incur
mrsa
transmiss
partial
compens
furthermor
everi
new
prevent
case
mrsa
potenti
impact
neg
public
imag
may
result
lost
revenu
due
cancel
admiss
hospit
eager
avoid
sinc
screen
patient
hospit
financi
viabl
costbenefit
consider
ultim
focus
patient
group
target
use
pcr
analysi
order
establish
mrsa
statu
quickli
screen
tradit
cultur
method
definit
answer
eg
larger
metaanalys
yet
avail
nevertheless
current
data
suggest
benefit
molecular
mrsa
screen
outweigh
cost
patient
particularli
high
mrsa
risk
eg
area
high
mrsa
preval
present
german
hospit
remain
hesit
long
gener
applic
recommend
issu
eg
robertkochinstitut
berlin
use
molecular
biolog
test
high
cost
organiz
constraint
mrsapcr
similar
lack
effect
hygien
manag
structur
prevent
screen
carri
answer
specif
question
mostli
quickli
manag
bed
capac
